Study of a new aortic valve for people needing valve replacement
Part of Heart & circulation clinical trials.
This study tests a new type of heart valve (called Venus-Neo) to see if it is safe and works well for people who need their aortic valve replaced. If you qualify, you may receive this valve as part of the study and be followed over time to ensure it is working properly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your doctor says you need an aortic valve replacement.
- You have not had any heart valve replacement or repair surgery before.
- You have not had a heart attack, stroke, or major heart procedure in the last 30 days (or 3 months for stroke).
- You do not have severe kidney disease (dialysis or very low kidney function) or other severe organ problems.
- You are willing to participate in follow-up visits and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new biological heart valve called 'UniLine' for people who need to replace their mitral valve (the valve between the left heart chambers) or aortic valve (the main valve sending blood to the body) for the first time. If you qualify, you would have planned surgery (not an emergency) and need to be free of certain other serious health conditions.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This study tests a new replacement valve for the aortic valve, which controls blood flow from the heart. It may help people with severe aortic valve narrowing or leaking who need surgery.
This study tests a biological (tissue) heart valve replacement system designed to be easier to change later. It may help people who need valve surgery because their valve is narrowed or damaged.
This study follows how the VitaFlow heart valve works in people age 70+ who have severe, narrowed aortic valves and cannot safely get open-heart valve surgery. It’s meant to see whether the device improves outcomes and is safe over time.
Hear when a new Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.